251 related articles for article (PubMed ID: 20131981)
21. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice.
Zhang L; Yang M; Wang Q; Li Y; Guo R; Jiang X; Yang C; Liu B
J Control Release; 2007 Jun; 119(2):153-62. PubMed ID: 17400320
[TBL] [Abstract][Full Text] [Related]
22. Preparation and
Zhou T; Tang X; Zhang W; Feng J; Wu W
Drug Deliv; 2019 Dec; 26(1):673-679. PubMed ID: 31266376
[TBL] [Abstract][Full Text] [Related]
23. Amphiphilic Hybrid Dendritic-Linear Molecules as Nanocarriers for Shape-Dependent Antitumor Drug Delivery.
Guo Y; Wang T; Zhao S; Han M; Dong Z; Wang X; Wang Y
Mol Pharm; 2018 Jul; 15(7):2665-2673. PubMed ID: 29782803
[TBL] [Abstract][Full Text] [Related]
24. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting.
Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z
Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739
[TBL] [Abstract][Full Text] [Related]
25. Promoted antitumor activities of acid-labile electrospun fibers loaded with hydroxycamptothecin via intratumoral implantation.
Luo X; Xu G; Song H; Yang S; Yan S; Jia G; Li X
Eur J Pharm Biopharm; 2012 Nov; 82(3):545-53. PubMed ID: 22995703
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of bioavailability of two kinds of solid dispersion from 10-hydroxycamptothecin in SD rats in vivo].
Wu XC; Hao HJ; Liu YX; Song XY; Zhang YZ; Zhang HQ
Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(6):1130-1134. PubMed ID: 28875682
[TBL] [Abstract][Full Text] [Related]
27. Sustained-release hydroxycamptothecin polybutylcyanoacrylate nanoparticles as a liver targeting drug delivery system.
Sun X; Wu F; Lu W; Zhang ZR
Pharmazie; 2004 Oct; 59(10):791-4. PubMed ID: 15544059
[TBL] [Abstract][Full Text] [Related]
28. Effect of alkyl chain on cellular uptake and antitumor activity of hydroxycamptothecin nanoparticles based on amphiphilic linear molecules.
Guo Y; Wang T; Zhao S; Qiu H; Han M; Dong Z; Wang X
Eur J Pharm Sci; 2018 Nov; 124():266-272. PubMed ID: 30189259
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization.
Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001
[TBL] [Abstract][Full Text] [Related]
30. Hydroxycamptothecin liposomes based on thermal and magnetic dual-responsive system: preparation, in vitro and in vivo antitumor activity, microdialysis-based tumor pharmacokinetics.
Zhu HM; Gu JH; Xie Y; Xie B; Ling JJ
J Drug Target; 2018 Apr; 26(4):345-356. PubMed ID: 28920483
[TBL] [Abstract][Full Text] [Related]
31. Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin.
Yuan Y; Wen J; Tang J; Kan Q; Ackermann R; Olsen K; Schwendeman A
Int J Nanomedicine; 2016; 11():6229-6238. PubMed ID: 27920529
[TBL] [Abstract][Full Text] [Related]
32. Hydroxyethyl starch-10-hydroxy camptothecin conjugate: synthesis, pharmacokinetics, cytotoxicity and pharmacodynamics research.
Li G; Cai C; Qi Y; Tang X
Drug Deliv; 2016; 23(1):277-84. PubMed ID: 24833272
[TBL] [Abstract][Full Text] [Related]
33. Mitochondria and nucleus delivery of active form of 10-hydroxycamptothecin with dual shell to precisely treat colorectal cancer.
Li HQ; Ye WL; Huan ML; Cheng Y; Liu DZ; Cui H; Liu M; Zhang BL; Mei QB; Zhou SY
Nanomedicine (Lond); 2019 Apr; 14(8):1011-1032. PubMed ID: 30925116
[TBL] [Abstract][Full Text] [Related]
34. Berberine-10-hydroxy camptothecine-loaded lipid microsphere for the synergistic treatment of liver cancer by inhibiting topoisomerase and HIF-1α.
Qi Y; Liu G
Drug Deliv; 2021 Dec; 28(1):171-182. PubMed ID: 33427515
[TBL] [Abstract][Full Text] [Related]
35. [Preparation and in vitro drug release study of long-circulating hydroxycamptothecin nanoparticles].
Xi N; Hou LB
Zhong Yao Cai; 2010 Apr; 33(4):610-3. PubMed ID: 20845792
[TBL] [Abstract][Full Text] [Related]
36. Hydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydroxy camptothecin.
Li G; Li Y; Tang Y; Zhang Y; Zhang Y; Yin T; Xu H; Cai C; Tang X
Int J Pharm; 2014 Aug; 471(1-2):234-44. PubMed ID: 24861941
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and Tissue Distribution of Folate-Decorated Human Serum Albumin Loaded With Nano-Hydroxycamptothecin for Tumor Targeting.
Wang W; Liang H; Sun B; Xu J; Zeng Z; Zhao X; Li Q
J Pharm Sci; 2016 Jun; 105(6):1874-1880. PubMed ID: 27129905
[TBL] [Abstract][Full Text] [Related]
38. A study of the synergistic effect of folate-decorated polymeric micelles incorporating Hydroxycamptothecin with radiotherapy on xenografted human cervical carcinoma.
You H; Fu S; Qin X; Yu Y; Yang B; Zhang G; Sun X; Feng Y; Chen Y; Wu J
Colloids Surf B Biointerfaces; 2016 Apr; 140():150-160. PubMed ID: 26752212
[TBL] [Abstract][Full Text] [Related]
39. Novel colon-specific microspheres with highly dispersed hydroxycamptothecin cores: their preparation, release behavior, and therapeutic efficiency against colonic cancer.
Lu B; Zhang Z
J Pharm Sci; 2006 Dec; 95(12):2619-30. PubMed ID: 16917869
[TBL] [Abstract][Full Text] [Related]
40. Lysine-mediated hydroxyethyl starch-10-hydroxy camptothecin micelles for the treatment of liver cancer.
Li G; Zhao M; Zhao L
Drug Deliv; 2020 Dec; 27(1):519-529. PubMed ID: 32228107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]